Abstract
Following the path of clinical applications of hybrid PET-CT it would seem logical that PET-MR can provide an innovative and attractive alternative taking full advantage of the superiority of MR over CT in differentiating soft tissue characteristics with a reduction in radiation exposure by replacing the CT with MR. The challenges of PET-MR are however, still numerous both on the technical side as on the practical and clinical side.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Antoch G, Bockisch A (2009) Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging 36 Suppl 1:S113–S120
Antoch G, Saoudi N, Kuehl H et al (2004) Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22:4357–4368
Bar-Shalom R, Yefremov N, Guralnik L et al (2003) Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 44:1200–1209
Beyer T, Pichler B (2009) A decade of combined imaging: from a PET attached to a CT to a PET inside an MR. Eur J Nucl Med Mol Imaging 36 Suppl 1:S1–S2
Beyer T, Weigert M, Quick HH et al (2008) MR-based attenuation correction for torso-PET/MR imaging: pitfalls in mapping MR to CT data. Eur J Nucl Med Mol Imaging 35:1142–1146
Chen W, Jian W, Li HT et al (2010) Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? Magn Reson Imaging 28:613–620
Collins CD (2007) PET/CT in oncology: for which tumours is it the reference standard? Cancer Imaging 7 Spec No A:S77–S87
Czernin J, Allen-Auerbach M, Schelbert HR (2007) Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med 48 Suppl 1:78S–88S
Delso G, Ziegler S (2009) PET/MRI system design. Eur J Nucl Med Mol Imaging 36 Suppl 1:S86–S92
Heusner TA, Kuemmel S, Umutlu L et al (2008) Breast cancer staging in a single session: whole-body PET/CT mammography. J Nucl Med 49:1215–1222
Heusner TA, Kuemmel S, Koeninger A et al (2010) Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging 37(6):1077–1086
Hofmann M, Pichler B, Scholkopf B, Beyer T (2009) Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur J Nucl Med Mol Imaging 36 Suppl 1:S93–S104
Hu Z, Ojha N, Renisch S et al (2009) MR-based attenuation correction for a whole-body sequential PET/MR system. In: IEEE nuclear science symposium conference record, Orlando, 2009, pp 3508–3512
Lonsdale MN, Beyer T (2010) Dual-modality PET/CT instrumentation-today and tomorrow. Eur J Radiol 73:452–460
Punwani S, Taylor SA, Bainbridge A et al (2010) Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging. Radiology 255:182–190
Schmidt GP, Reiser MF, Baur-Melnyk A (2009) Whole-body MRI for the staging and follow-up of patients with metastasis. Eur J Radiol 70:393–400
Shao Y, Cherry SR, Farahani K et al (1997) Simultaneous PET and MR imaging. Phys Med Biol 42:1965–1970
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ratib, O., Schwaiger, M. (2013). Introduction. In: Ratib, O., Schwaiger, M., Beyer, T. (eds) Atlas of PET/MR Imaging in Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31292-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-31292-2_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31291-5
Online ISBN: 978-3-642-31292-2
eBook Packages: MedicineMedicine (R0)